Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy

Neurobiology of Aging

Volumn 36, Issue 9, 2015, Pages 2597-2606

  Schmitz, Matthias ^a   Hermann, Peter ^a   Oikonomou, Pantelis ^a   Stoeck, Katharina ^a   Ebert, Elisabeth ^a   Poliakova, Tatjana ^b   Schmidt, Christian ^a   Llorens, Franc ^a   Zafar, Saima ^a   Zerr, Inga ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Russian Academy of Advanced Medical Studies   (Russian Federation)

Author keywords

Cellular prion protein; Cytokines; Neuroinflammation; Vascular dementia; Vascular encephalopathy

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PRION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; PRION; TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN DISEASE; CAMBRIDGE COGNITIVE EXAMINATION BATTERY TEST; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DEMENTIA ASSESSMENT; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; VASCULAR ENCEPHALOPATHY; VASCULAR LESION; AGED; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PRION; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CYTOKINES; DEMENTIA, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PRIONS; TAU PROTEINS;

EID: 84940467258     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.05.013     Document Type: Article

References (50)

1. Alvarez X.A., Franco A., Fernández-Novoa L., Cacabelos R. Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease. Mol. Chem. Neuropathol. 1996, 29:237-252.
2. Barclay G.R., Hope J., Birkett C.R., Turner M.L. Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry. Br. J. Haematol. 1999, 107:804-814.
3. Baezner H., Daffertshofer M. Subcortical vascular encephalopathy. Ther. Umsch. 2003, 60:541-552.
4. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Purzuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 1995, 202:17-20.
5. Brown K.L., Ritchie D.L., McBride P.A., Bruce M.E. Detection of PrP in extraneural tissues. Microsc. Res. Tech. 2000, 50:40-45.
6. Cacquevel M., Lebeurrier N., Chéenne S., Vivien D. Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets 2004, 5:529-534.
7. Cunningham C., Campion S., Lunnon K., Murray C.L., Woods J.F., Deacon R.M., Rawlins J.N., Perry V.H. Systematic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 2009, 65:304-312.
8. De Luigi A., Pizzimenti S., Quadri P., Lucca U., Tettamanti M., Fragiacomo C., De Simoni M.G. Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia. Neurobiol. Dis. 2002, 11:308-314.
9. De Simoni M.G., Del Bo R., De Luigi A., Simard S., Forloni G. Central endotoxin induces different patterns of interleukin (IL)- 1 beta and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology 1995, 136:897-902.
10. Di Bona D., Plaia A., Vasto S., Cavallone L., Lescai F., Franceschi C., Licastro F., Colonna-Romano G., Lio D., Candore G., Caruso C. Association between the interleukin-1 beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res. Rev. 2008, 59:155-163.
11. Durig J., Giese A., Schulz-Schaeffer W., Rosenthal C., Schmucker U., Bieschke J., Dührsen U., Kretzschmar H.A. Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes. Br. J. Haematol. 2000, 108:488-495.
12. Hu W., Nessler S., Hemmer B., Eagar T.N., Kane L.P., Leliveld S.R., Müller-Schiffmann A., Gocke A.R., Lovett-Racke A., Ben L.H., Hussain R.Z., Breil A., Elliott J.L., Puttaparthi K., Cravens P.D., Singh M.P., Petsch B., Stitz L., Racke M.K., Korth C., Stüve O. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling. Brain 2010, 133:375-388.
13. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010, 120:287-296.
14. Ingram R.J., Isaacs J.D., Kaur G., Lowther D.E., Reynolds C.J., Boyton R.J., Collinge J., Jackson G.S., Altmann D.M. Arole of cellular prion protein in programming T-cell cytokine responses in disease. FASEB J. 2009, 23:1672-1684.
15. Konturek P.C., Bazela K., Kukharskyy V., Bauer M., Hahn E.G., Schuppan D. Helicobacter pylori up regulates prion protein expression in gastric mucosa: a possible link to prion disease. World J. Gastroenterol. 2005, 11:7651-7656.
16. Krabbe K.S., Pedersen M., Bruunsgaard H. Inflammatory mediators in the elderly. Exp. Gerontol. 2004, 39:687-699.
17. Lee K.S., Chung J.H., Choi T.K., Suh S.Y., Oh B.H., Hong C.H. Peripheral cytokines and chemokines in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2009, 28:281-287.
18. Linden R., Martins V.R., Prado M.A., Cammarota M., Izquierdo I., Brentani R.R. Physiology of the prion protein. Physiol. Rev. 2008, 88:673-728.
19. Lu C.Z., Xiao B.G. Neuroptotection of G-CSF in cerebral ischemia. Front. Biosci. 2007, 12:2869-2875.
20. Marques F., Sousa J.C., Sousa N., Palha J.A. Blood-brain-barriers in aging and in Alzheimer's disease. Mol. Neurodegener. 2013, 8:38.
21. Mattei V., Garofalo T., Misasi R., Circella A., Manganelli V., Lucania G., Pavan A., Sorice M. Prion protein is a component of the multimolecular signaling complex involved in T cell activation. FEBS Lett. 2004, 560:14-18.
22. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
23. McLennan N.F., Brennan P.M., McNeill A., Davies I., Fotheringham A., Rennison K.A., Ritchie D., Brannan F., Head M.W., Ironside J.W., Williams A., Bell J.E. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am. J. Pathol. 2004, 165:227-235.
24. Moorhouse P., Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol. 2008, 7:246-255.
25. Paganelli R., Di Iorio A., Patricelli L., Ripani F., Sparvieri E., Faricelli R., Iarlori C., Porreca E., Di Gioacchino M., Abate G. Prioninflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients. Exp. Gerontol. 2002, 37:257-263.
26. Parkin E.T., Watt N.T., Hussain I., Eckman E.A., Eckman C.B., Manson J.C., Baybutt H.N., Turner A.J., Hooper N.M. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11062-11067.
27. Peters P.J., Mironov A.J., Peretz D., van Donselaar E., Leclerc E., Erpel S., DeArmond S.J., Burton D.R., Williamson R.A., Vey M., Prusiner S.B. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J.Cell Biol. 2003, 162:703-717.
28. Reape T.J., Groot P.H. Cemokines and atherosclerosis. Atherosclerosis 1999, 147:213-225.
29. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 1986, 149:698-709.
30. Rubio-Perez J.M., Morillas-Ruiz J.M. Areview: inflammatory process in Alzheimer's disease, role of cytokines. Scientific World Journal 2012, 2012:756357.
31. Sauer H., Wefer K., Vetrugno V., Pocchiari M., Gissel C., Sachinidis A., Hescheler J., Wartenberg M. Regulation of intrinsic prion protein by growth factors and TNF-alpha: the role of intracellular reactive oxygen species. Free Radic. Biol. Med. 2003, 35:586-594.
32. Schielke G.P., Yang G.Y., Shivers B.D., Betz A.L. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J.Cereb. Blood Flow Metab. 1998, 18:180-185.
33. Schmitz M., Klöppner S., Klopfleisch S., Möbius W., Schwartz P., Zerr I., Althaus H.H. Mutual effects of caveolin and nerve growth factor signaling in pig oligodendrocytes. J.Neurosci. Res. 2010, 88:572-588.
34. Schmitz M., Lüllmann K., Zafar S., Ebert E., Wohlhage M., Oikonomou P., Schlomm M., Mitrova E., Beekes M., Zerr I. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic of familial prion diseases. Neurobiol. Aging 2014, 35:1177-1188.
35. Schmitz M., Schlomm M., Hasan B., Beekes M., Mitrova E., Korth C., Breil A., Carimalo J., Gawinecka J., Varges D., Zerr I. Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease. Eur. J. Neurosci. 2010, 31:2024-2031.
36. Schmitz M., Signore S.C., Zerr I., Althaus H.H. Oligodendroglial process formation is differentially affected by modulating the intra- and extracellular cholesterol content. J.Mol. Neurosci. 2013, 49:457-469.
37. Schmitz M., Wulf K., Signore S.C., Schulz-Schaeffer W., Kermer P., Bähr M., Wouters F.S., Zafar S., Zerr I. Impact of the cellular prion protein on amyloid-βand 3PO-tau processing. J.Alzheimers Dis. 2014, 38:551-565.
38. Sevimli S., Diederich K., Strecker J.K., Schilling M., Klocke R., Nikol S., Kirsch F., Schneider A., Schäbitz W.R. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp. Neurol. 2009, 217:328-335.
39. Starke R., Drummond O., MacGregor I., Biggersta V.J., Gale R., Camilleri R., Mackie I., Machin S., Harrison P. The expression of prion protein by endothelial cells: a source of the plasma form of prion protein?. Br. J. Haematol. 2002, 119:863-873.
40. Starke R., Harrison P., Gale R., Mackie I., Drummond O., MacGregor I., Machin S. Endothelial cells express normal cellular prion protein. Br. J. Haematol. 2003, 123:372-373.
41. Stoeck K., Schmitz M., Ebert E., Schmidt C., Zerr I. Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer's disease and multiple sclerosis. J.Neuroinflammation 2014, 11:170.
42. Stuart M.J., Baune B.T. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci. Biobehav. Rev. 2014, 42:93-115.
43. Tarkowski E., Liljeroth A.M., Minthon L., Tarkowski A., Wallin A., Blennow K. Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res. Bull. 2003, 61:255-260.
44. Tazaki E., Shimizu N., Tanaka R., Yoshizumi M., Kamma H., Imoto S., Mukhamedyarov M.A., Zefirov A.L., Janka Z., Palotás A. Serum cytokine profiles in patients with prostate carcinoma. Exp. Ther. Med. 2011, 2:887-891.
45. Teixeira A.L., Reis H.J., Coelho F.M., Carneiro D.S., Teixeira M.M., Vieira L.B., Mukhamedyarov M.A., Zefirov A.L., Janka Z., Palotás A. All or nothing type biphasic cytokine production of human lymphocytes after exposure to Alzheimer's beta-amyloid peptide. Biol. Psychiatry 2008, 64:891-895.
46. Wada-Isoe K., Wakutani Y., Urakami K., Nakashima K. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol. Scand. 2004, 110:124-127.
47. Wahlund L.O., Barkhof F., Fazekas F., Bronge L., Augustin M., Sjögren M., Wallin A., Ader H., Leys D., Pantoni L., Pasquier F., Erkinjuntti T., Scheltens P. Anew rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001, 32:1318-1322.
48. Weise J., Crome O., Sandau R., Schulz-Schaeffer W., Bähr M., Zerr I. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci. Lett. 2004, 372:146-150.
49. Weise J., Sandau R., Schwarting S., Crome O., Wrede A., Schulz-Schaeffer W., Zerr I., Bähr M. Deletion of cellular prion protein results in reduced Akt activation, enhancedpostischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 2006, 37:1296-1300.
50. Wilcox J.N., Nelken N.A., Coughlin S.R., Gordon D., Schall T.J. Local expression of inflammatory cytokines in human atherosclerotic plaques. J.Atheroscler. Thromb. 1994, 1(Suppl 1):S3-S10.